Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Citizens Financial

Start price
Target price
Perf. (%)
€27.20
21.11.20
-
21.11.21
15.44%
22.01.21

Revenue growth >5% per year expected
EBIT decline/stagnation expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
buy
Starbucks Corp.

Start price
Target price
Perf. (%)
€82.11
20.11.20
-
2.28%
17.12.20

buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€437.60
19.11.20
€426.00
19.11.21
1.19%
23.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

buy
Amazon.com Inc.

Start price
Target price
Perf. (%)
€133.58
16.11.20
-
16.11.21
0.24%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
American Water Works Corp. Inc.

Start price
Target price
Perf. (%)
€138.12
14.11.20
€155.00
14.11.21
10.30%
06.08.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.30
14.11.20
-
14.11.21
-1.75%
23.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Qualcomm Inc.

Start price
Target price
Perf. (%)
€123.48
14.11.20
€150.00
14.05.21
-14.32%
14.05.21

buy
Verisk Analytics A

Start price
Target price
Perf. (%)
€174.02
13.11.20
-
13.11.21
-9.85%
13.02.21

EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very low/no dividend yield expected
buy
International Business Machines Corp

Start price
Target price
Perf. (%)
€98.48
13.11.20
€118.00
13.11.21
5.71%
14.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
buy
Procter & Gamble Co.

Start price
Target price
Perf. (%)
€120.88
13.11.20
-
-14.54%
01.03.21

buy
International Business Machines Corp

Start price
Target price
Perf. (%)
€98.00
13.11.20
-
13.11.21
26.48%
10.06.21

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.60
13.11.20
€52.00
1.38%
14.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Apple Inc.

Start price
Target price
Perf. (%)
€101.48
13.11.20
€110.00
3.84%
16.12.20

positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
buy
T-Mobile US Inc.

Start price
Target price
Perf. (%)
€106.88
12.11.20
€110.00
4.79%
14.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Truist Financial Corp.

Start price
Target price
Perf. (%)
€41.60
11.11.20
-
11.11.21
5.29%
14.01.21

Very high dividend yield expected
Probably not worthwhile Investment
Business model of the past or high risk
buy
General Motors Corp

Start price
Target price
Perf. (%)
€35.30
11.11.20
-
9.92%
25.11.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.00
09.11.20
€55.00
2.66%
10.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Walmart Inc.

Start price
Target price
Perf. (%)
€124.80
09.11.20
-
09.11.21
2.13%
25.11.20